Investor
Relations
Why sudair pharma?
In the year 2014, Sudair Pharma company (SPC) , launched the idea of building a New Pharmaceutical Industrial Complex , with a main target to secure the supply of high technology pharmaceutical manufactured products in KSA and MENA region, and thus decrease the dependency on importing such critical products from outside the region.
Financial Highlights - Q2 FY 2025
SAR
401
mn
Revenue
SAR
194
mn
Gross Profit
SAR
96
mn
EBITDA
Latest Quarterly Result- Q2 FY 2025

Financial Statements

Earnings Release

Earnings Presentation

Data Supplement
Contact information for
Investor Relations (IR) department
At Sudair Pharma (SPC), we aim to manufacture and create value-added pharmaceuticals that enhance the availability of specialized medicines through our investment and support in people who work at SPC

Call or text us
877-973-3287

Email
consult@financialrescuellc.com
IPO Timeline

Audited financial statements

Financial Reports - 2025
Financial Reports - 2024
Financial Reports - 2023
Announcements
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
Events
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
24/07/2025
SPC Pharmaceuticals Factory Co. announces t…
Major shareholders (5%+ ownership)
At Sudair Pharma (SPC), we aim to manufacture and create value-added pharmaceuticals that enhance the availability of specialized medicines through our investment and support in people who work at SPC, as well as partnering with the best to build an innovative culture that makes the difference to our community and for all those in need of SPC’s medications.
We are proud of SPC as a great national achievement, which is in line with the Kingdom of Saudi Arabia’s 2030 vision. This would not have been possible without the tremendous support provided by the government, in addition to the confidence that our elite customers and employees have given us.
Zakat/Tax compliance disclosure
At Sudair Pharma (SPC), we aim to manufacture and create value-added pharmaceuticals that enhance the availability of specialized medicines through our investment and support in people who work at SPC, as well as partnering with the best to build an innovative culture that makes the difference to our community and for all those in need of SPC’s medications.